English
|
正體中文
|
简体中文
|
Items with full text/Total items : 12145/12927 (94%)
Visitors : 904074 Online Users : 830
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by
NTU Library IR team.
Scope
All of NHRI
生技與藥物研究所
張俊彥
--期刊論文
Tips:
please add "double quotation mark" for query phrases to get precise results
please goto advance search for comprehansive author search
Adv. Search
Home
‧
Login
‧
Upload
‧
Help
‧
About
‧
Administer
國家衛生研究院 NHRI
>
生技與藥物研究所
>
張俊彥
>
Browse By Title
Browse By Authors
Browse By Date
Browse By Data Type
Community Detail
Introduction:
NA
Loading...
Collection
期刊論文
[
18
/18]
Siblings
伍素瑩
[
52
/65]
其他
[
58
/60]
夏克山
[
76
/98]
岳嶽
[
29
/32]
張仲明
[
7
/9]
張竣評
[
21
/26]
徐祖安
[
170
/215]
李秀珠
[
75
/105]
李靜琪
[
23
/24]
林書玉
[
19
/20]
洪明秀
[
31
/40]
潘秀玲(2009-2013)
[
16
/17]
王文傑
[
13
/15]
王鴻俊
[
7
/7]
石全(2014-2017)
[
35
/39]
童俊維
[
23
/23]
紀雅惠
[
21
/25]
翁紹華
[
22
/24]
莊宏
[
1
/1]
葉修華
[
24
/25]
葉燈光
[
133
/152]
蔣維棠
[
41
/66]
謝興邦
[
171
/231]
趙宇生(2002-2013)
[
120
/212]
郭靜娟
[
49
/55]
鄒倫
[
28
/29]
陳志豪
[
31
/52]
陳新(2002-2015)
[
53
/67]
陳炯東
[
180
/212]
顏婉菁
[
6
/7]
許明珠(1997-2001)
[
3
/10]
陳淑貞(1998-2001)
[
3
/11]
陳華鍵(1997-2001)
[
9
/9]
Community Statistics
近3年內發表的文件:10(55.56%)
含全文筆數:18(100.00%)
文件下載次數統計
下載大於0次:18(100.00%)
下載大於100次:17(94.44%)
檔案下載總次數:3863(0.07%)
最後更新時間: 2024-12-01 00:18
Top Upload
Loading...
Top Download
Loading...
Recent Submissions
Macrophage-mediated controlled rele...
Targeting cathepsin S promotes acti...
Lysosomal-targeted doxorubicin deli...
How to deal with frenemy NRF2: Targ...
Synthesis and structure–activity re...
The synergistic inhibition of coron...
MiR-455-5p suppresses PDZK1IP1 to p...
The synergistic inhibition of coron...
Lon upregulation contributes to cis...
Discovery of potential neuroprotect...
Jump to a point in the index:
(Choose year)
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1985
1980
1975
1970
1960
1950
(Choose month)
January
February
March
April
May
June
July
August
September
October
November
December
Or type in a year:
Ordering With Most Recent First
Show Oldest First
Showing items 1-18 of 18. (1 Page(s) Totally)
1
View [
10
|
25
|
50
] records per page
Date
Title
Relation
2024-06-24
Macrophage-mediated controlled release of cysteine protease inhibitor from PLGA-PEG/hydroxyapatite microspheres for targeting cathepsin S in Alzheimer's disease
European Polymer Journal. 2024 Jun 24;214:Article number 113151.
2024-05-09
Targeting cathepsin S promotes activation of OLF1-BDNF/TrkB axis to enhance cognitive function
Journal of Biomedical Science. 2024 May 09;31:Article number 46.
2023-11
Lysosomal-targeted doxorubicin delivery using RBC-derived vesicles to overcome drug-resistant cancer through mitochondrial-dependent cell death
Pharmacological Research. 2023 Nov;197:Article number 106945.
2023-03-28
Synthesis and structure–activity relationship of salvinal derivatives as potent microtubule inhibitors
International Journal of Molecular Sciences. 2023 Mar 28;24(7):Article number 6386.
2023-02-28
How to deal with frenemy NRF2: Targeting NRF2 for chemoprevention and cancer therapy
Journal of Food and Drug Analysis. 2023 Feb 28;31(3):387-407.
2023-02-03
MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition
Journal of Experimental and Clinical Cancer Research. 2023 Feb 3;42:Article number 40.
2023-01-19
The synergistic inhibition of coronavirus replication and induced cytokine production by ciclesonide and the tylophorine-based compound dbq33b [Erratum:Pharmaceutics. 2022 Jul 21;14(7):Article number 1511.]
Pharmaceutics. 2023 Jan 19;15(2):Article number 342.
2022-07-21
The synergistic inhibition of coronavirus replication and induced cytokine production by ciclesonide and the tylophorine-based compound dbq33b
Pharmaceutics. 2022 Jul 21;14(7):Article number 1511.
2022-03-16
Lon upregulation contributes to cisplatin resistance by triggering NCLX-mediated mitochondrial Ca2+ release in cancer cells
Cell Death and Disease. 2022 Mar 16;13(3):Article number 241.
2022-03-02
Discovery of potential neuroprotective agents against paclitaxel-induced peripheral neuropathy
Journal of Medicinal Chemistry. 2022 Mar 2;65(6):4767-4782.
2021-12-14
A novel NRF2/ARE inhibitor gossypol induces cytotoxicity and sensitizes chemotherapy responses in chemo-refractory cancer cells
Journal of Food and Drug Analysis. 2021 Dec 14;29(4):638-652.
2021-11-09
MicroRANs: Their role in metabolism, tumor microenvironment, and therapeutic implications in head and neck squamous cell carcinoma
Cancers. 2021 Nov 9;13(22):Article number 5604.
2021-08-13
Remdesivir and cyclosporine synergistically inhibit the human coronaviruses OC43 and SARS-CoV-2
Frontiers in Pharmacology. 2021 Aug 13;12:Article number 706901.
2021-06
Investigating the association between serum human papillomavirus type 16 E7 antibodies and risk of head and neck cancer
Cancer Medicine. 2021 Jun;10(12):4075-4086.
2021-03-11
c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation
Theranostics. 2021 Mar 11;11(11):5232-5247.
2021-03-04
Targeting lysosomal cysteine protease cathepsin S reveals immunomodulatory therapeutic strategy for oxaliplatin-induced peripheral neuropathy
Theranostics. 2021 Mar 4;11(10):4672-4687.
2021-03-01
Phase I dose escalation study of sorafenib plus S-1 for advanced solid tumors
Scientific Reports. 2021 Mar 1;11:Article number 4834.
2021-02-24
New insights into oral squamous cell carcinoma: From clinical aspects to molecular tumorigenesis
International Journal of Molecular Sciences. 2021 Feb 24;22(5):Article number 2252.
Showing items 1-18 of 18. (1 Page(s) Totally)
1
View [
10
|
25
|
50
] records per page
DSpace Software
Copyright © 2002-2004
MIT
&
Hewlett-Packard
/
Enhanced by
NTU Library IR team
Copyright ©
-
Feedback